Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.1.900
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents [1] $ 193,598 $ 96,907
Accounts receivable, net [1] 193,875 19,969
Inventory, net [1] 39,681 16,604
Prepaid expenses and other current assets [1] 26,904 9,389
Total current assets [1] 454,058 142,869
Property, plant and equipment, net [1] 131,798 16,411
Intangible assets, net [1] 638,152 62,649
In-process research and development [1] 792,275 793,152
Goodwill [1] 743,348 224,292
Investments, net [1] 34,716 22,453
Other assets [1] 5,267 5,838
Total assets [1] 2,799,614 1,267,664
Current liabilities:    
Accounts payable [1] 72,535 8,744
Accrued expenses [1] 167,899 60,912
Current portion of lines of credit and notes payable [1] 11,468 13,455
Total current liabilities [1] 251,902 83,111
2033 Senior Notes, net of discount and estimated fair value of embedded derivatives [1] 49,412 131,454
Deferred tax liabilities, net 226,036 167,153
Other long-term liabilities, principally deferred revenue [1] 292,470 50,205
Total long-term liabilities [1] 567,918 348,812
Total liabilities [1] 819,820 431,923
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 546,188,516 and 433,421,677 shares issued at December 31, 2015 and 2014, respectively [1] 5,462 4,334
Treasury Stock, at cost - 1,120,367 and 1,245,367 shares at December 31, 2015 and 2014, respectively [1] (3,645) (4,051)
Additional paid-in capital [1] 2,705,385 1,529,096
Accumulated other comprehensive loss [1] (22,537) (12,392)
Accumulated deficit [1] (704,871) (674,843)
Total shareholders’ equity attributable to OPKO [1] 1,979,794 842,144
Noncontrolling interests [1] 0 (6,403)
Total shareholders’ equity [1] 1,979,794 835,741
Total liabilities and equity [1] $ 2,799,614 1,267,664
Variable interest entity, total assets   7,600
Variable interest entity, total liabilities   $ 12,100
[1] As of December 31, 2014, total assets include $7.6 million and total liabilities include $12.1 million related to SciVac Ltd (“SciVac”). SciVac was a consolidated variable interest entity which we deconsolidated in July 2015. Refer to Note 4. SciVac’s consolidated assets were owned by SciVac and SciVac’s consolidated liabilities had no recourse against us.